CiteFacts · FDA Drug Shortages · FDA source
Atropine Sulfate Injection
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Accord Healthcare Inc. | Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03) | Unavailable | 08/17/2026 |
| Accord Healthcare Inc. | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90) | Unavailable | 08/17/2026 |
| Accord Healthcare Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43) | Unavailable | 08/17/2026 |
| Accord Healthcare Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08) | Unavailable | 08/17/2026 |
| Accord Healthcare Inc. | Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45) | Available | 08/17/2026 |
| Accord Healthcare Inc. | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08) | Unavailable | 08/17/2026 |
| American Regent, Inc. | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25) | Available | 08/17/2026 |
| American Regent, Inc. | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25) | Available | 08/17/2026 |
| Amphastar Pharmaceuticals, Inc. | Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1) | Available | 08/18/2026 |
| Fresenius Kabi USA, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20) | Available | 08/04/2026 |
| Hikma Pharmaceuticals USA, Inc. | Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10) | Available | 08/13/2026 |
| Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult) 0.5 mg/5 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4910-34)" | Not stated | 11/07/2025 |
| Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" | Not stated | 11/07/2025 |
| Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, (Adult)1 mg/10 mL (0.1 mg/mL) LifeShield® ABBOJECT® Glass Syringe (20 G x 1 1/2) (NDC 0409-4911-34)" | Unavailable | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05) | Available | 08/07/2026 |
| Hospira, Inc., a Pfizer Company | Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10) | Unavailable | 08/07/2026 |
| Medefil, Inc. | Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91) | Available | 08/17/2026 |
| Somerset Therapeutics, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25) | Available | 07/20/2026 |
| Somerset Therapeutics, LLC | Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25) | Available | 07/20/2026 |
Source facts
Grouped generic ingredient: Atropine Sulfate Injection · 21 package records · Latest FDA row update: 11/07/2025
Therapeutic categories: Anesthesia, Neurology, Pediatric
Dosage forms: Injection
Routes: ENDOTRACHEAL, INTRAMEDULLARY, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.